Three highlights of the plan:
1. Mr. Buttigieg’s plan would allow the federal government to negotiate drug prices for Medicare and his public option plan, first targeting prices for drugs that treat diabetes, asthma, arthritis, HIV and cancer.
2. He pledged to cut Medicare out-of-pocket spending on drugs in half by the end of his first term. Monthly out-of-pocket costs for prescription drugs would be capped at $200 for Medicare enrollees and $250 for people with the public option. Low-income Americans with coverage under the public option, Medicare or Medicaid would not be required to pay a co-pay for generic drugs.
3. His administration would increase taxes on pharmaceutical companies, which is intended to help fund the plan. It would also require drug companies to pay rebates when prices increase faster than inflation. If a pharmaceutical company engages in “abusive pricing” practices, Mr. Buttigieg pledged to revoke the company’s patents.
Read more about his drug pricing platform here.
More articles on leadership and management:
Michigan hospital restructures board about a month after CEO’s firing
Immigrant visas contingent on health insurance under new Trump rule
Michael Dowling: Health reform begins with making better lifestyle choices
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.